We are live on
!
Find out more
MAM
MPM Asset Management Portfolio holdings
AUM
$44.5M
1-Year Est. Return
47.28%
This Fund
S&P 500
This Quarter
Est. Return
+9.74%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$258M
AUM Growth
-$1.46M
(-0.56%)
Cap. Flow
+$10.3M
Cap. Flow
% of AUM
4.01%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
1
Reduced
1
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rhythm Pharmaceuticals
RYTM
|
+$10.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RDUS
Radius Health, Inc.
RDUS
|
+$3.16K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
WCPI
BAM
WAMC
NLVP
CIEP
IPI
CC
VSAM
MPM Asset Management's Q2 2018 Portfolio in Review
As of Q2 2018, MPM Asset Management held 9 positions worth $258M, down 0.56% from $260M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
MPM Asset Management deployed $10.3M of net new capital in Q2 2018, adding to 1 existing holding.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
On the sell side, the largest reduction was Radius Health, Inc., an estimated $3.16K trimmed.
- MPM Asset Management added most to Rhythm Pharmaceuticals in Q2 2018, an estimated $10.3M increase.
- MPM Asset Management's biggest Q2 2018 reduction was Radius Health, Inc., cutting an estimated $3.16K.
- MPM Asset Management's ten largest holdings make up 100% of its $258M portfolio in Q2 2018.
- MPM Asset Management opened 0 new positions and closed 0 in Q2 2018.
- MPM Asset Management's portfolio value fell 0.56% quarter-over-quarter to $258M.
Based on MPM Asset Management's 13F filing for Q2 2018, filed 13 Aug 2018.